StonvexLoading…
StonvexStonvexStonvexCore line items from PNTG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-04 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $294.39M | $285.36M | $947.71M | $658.38M | $429.34M |
Operating Income | Not available | $17.30M | $51.89M | $34.42M | $24.18M |
Net Income | Not available | $8.52M | $29.58M | $20.94M | $7.08M |
EPS (Diluted) | $0.34 | $0.24 | $0.84 | $0.59 | $0.42 |
Total Assets | Not available | $956.48M | $968.18M | $753.64M | $751.42M |
Total Liabilities | Not available | $567.05M | $593.93M | $410.60M | $417.79M |
Cash & Equivalents | Not available | $4.91M | $17.02M | $2.34M | $14.38M |
Free Cash Flow OCF − CapEx | Not available | $-8.68M | $36.26M | $18.86M | $8.39M |
Shares Outstanding | Not available | 34.75M | 34.63M | 34.57M | 34.49M |